FectoVIR® AAV Transfection Reagent For Large-Scale rAAV Manufacturing

FectoVIR®-AAV is a cutting-edge synthetic transfection reagent designed for the industrial-scale production of recombinant AAV (rAAV) in both suspension and adherent HEK293-derived cell systems. It supports higher rAAV titers, improves large-scale production scalability, and reduces manufacturing risks. FectoVIR®-AAV-GMP is produced under a validated aseptic process per ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Explore detailed product features, relevant applications, and more.